Restaging oesophageal cancer after neoadjuvant therapy with 18 F-FDG PET-CT: identifying interval metastases and predicting incurable disease at surgery
2016
Objectives
It is unknown whether restaging oesophageal cancer after neoadjuvant therapy with positron emission tomography-computed tomography (PET-CT) is more sensitive than contrast-enhanced CT for disease progression. We aimed to determine this and stratify risk.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
40
References
19
Citations
NaN
KQI